IDA Trading MEA Pharmaceutical Import Profile — United Arab Emirates (DGFT 2022–2026)

Name: IDA Trading MEA Pharmaceutical Import Records from India — 2 Products, $332.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

IDA Trading MEA — Pharmaceutical Importer Profile (2026) | 2 Products, $332.7K Trade | TransData Nexus

IDA Trading MEA

Pharmaceutical Importer · United Arab Emirates · Antifungals Focus · $332.7K Total Trade · DGFT Verified

IDA Trading MEA is a pharmaceutical importer based in United Arab Emirates with a total trade value of $332.7K across 2 products in 2 therapeutic categories. Based on 32 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. IDA Trading MEA sources from 33 verified Indian suppliers, with Medopharm accounting for 37.2% of imports.

IDA Trading MEA — Import Portfolio & Supplier Network

IDA Trading MEA import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to IDA Trading MEA?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Medopharm	$6.2M	501	37.2%
Micro Labs Limited	$1.4M	127	8.5%
Ipca Laboratories Limited	$1.4M

What Formulations Does IDA Trading MEA Import?

Formulation	Value	Ships
Compound sodium lactate intravenous	$363.3K	38
Vitamin a 200000 IU capsules (retinol)	$261.5K	7
Pharma. goods/harmless	$239.2K	5
Pharmaceutical products: doxycycline	$211.5K	14
Pharmaceutical products: miconazole	$188.9K	13
Pharma goods/harmless	$162.4K	7
Dispersible paracetamol tablets BP 100MG	$151.4K	10
Amoxicillin 125 MG / 5 ML oral	$146.5K	9
Indian harmless medicines	$140.8K	16
Oral rehydration salts BP 20.5g/l ida	$138.9K	12
Amoxicillin oral suspension BP 125MG/5ML	$124.2K	6
Ciprofloxacin tablets USP 250MG(12000	$117.4K	3
Pharmaceutical products: azithromycin	$117.4K	6
Fluoxetine capsules BP 20MG (5000 x 10	$107.4K	3
Cloxacillin sodium capsules USP 250MG	$103.7K	3

IDA Trading MEA imports 870 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Miconazole	Antifungals	$191.9K	16	1.0%	15
2	Tetracycline	Antibiotics	$140.8K	16	0.8%	13

IDA Trading MEA imports 2 pharmaceutical products across 2 categories into United Arab Emirates totaling $332.7K.

IDA Trading MEA — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

IDA Trading MEA is a pharmaceutical importer and buyer based in the United Arab Emirates (UAE). The company specializes in sourcing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. With a total import value of $333,000 USD over 32 shipments, IDA Trading MEA focuses on two therapeutic categories: antifungals and antibiotics. The company's top five imported products are miconazole ($192,000 USD) and tetracycline ($141,000 USD), accounting for 100% of their import portfolio. This indicates a highly concentrated sourcing strategy, relying exclusively on these two products.

2Distribution Network

While specific details about IDA Trading MEA's warehouse locations and logistics capabilities are not publicly available, the company's import activities suggest a well-established distribution network within the UAE. The focus on antifungals and antibiotics indicates a strategic alignment with the UAE's healthcare needs, particularly in the treatment of infectious diseases. IDA Trading MEA's operations likely involve partnerships with local distributors and healthcare providers to ensure efficient delivery and availability of these essential medications.

3Industry Role

IDA Trading MEA functions as a pharmaceutical importer and buyer within the UAE's pharmaceutical supply chain. By sourcing finished pharmaceutical formulations from Indian manufacturers, the company plays a crucial role in ensuring the availability of essential medications in the UAE market. Their focus on specific therapeutic categories, such as antifungals and antibiotics, positions them as a specialized importer catering to targeted healthcare needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — IDA Trading MEA

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

IDA Trading MEA's sourcing strategy exhibits a high degree of concentration, importing exclusively two products—miconazole and tetracycline—which together constitute 100% of their import portfolio. This approach suggests a strategic focus on these products, possibly due to consistent demand or favorable market conditions. However, such concentration also exposes the company to risks associated with supply chain disruptions, regulatory changes, or market fluctuations affecting these specific products. The absence of diversification in their product range may limit their ability to adapt to changing market dynamics or consumer preferences.

2Supply Chain Resilience

IDA Trading MEA's supply chain resilience is closely tied to the stability and reliability of their Indian suppliers. The company's imports are sourced from a diverse group of 33 unique Indian suppliers, with the top five suppliers accounting for a significant portion of the total import value. This diversified supplier base can mitigate risks associated with dependency on a single source. However, the company's exclusive focus on two products may limit their ability to adapt to changes in the supply chain or market demand. Additionally, the resilience of their supply chain is contingent upon the regulatory compliance and operational stability of their Indian suppliers.

Importing Pharmaceuticals into United Arab Emirates — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Arab Emirates

1Regulatory Authority & Framework

The UAE's pharmaceutical sector is regulated by the Ministry of Health and Prevention (MOHAP), which oversees the import, distribution, and sale of medical products. Key legislation governing pharmaceutical imports includes the Federal Decree-Law No. 8 of 2019 on Medical Products, Pharmacy Profession, and Pharmaceutical Facilities. This law outlines the requirements for importing medical products, including obtaining necessary approvals and permits from the Emirates Drug Establishment (EDE). The MOHAP is responsible for ensuring that imported pharmaceutical products meet the safety, quality, and efficacy standards set by the UAE.

2Import Licensing & GMP

Import licensing in the UAE requires pharmaceutical establishments to obtain approvals from the EDE for each shipment of medical products. These approvals are contingent upon compliance with Good Manufacturing Practice (GMP) standards recognized by the UAE, such as EU GMP, WHO GMP, or PIC/S certifications. Pharmaceutical establishments must also possess wholesale distribution authorizations to import and distribute medical products within the UAE. This regulatory framework ensures that imported pharmaceutical products are safe, effective, and of high quality.

Quality & Labeling

IDA Trading MEA — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

IDA Trading MEA's focus on importing antifungals and antibiotics aligns with the UAE's healthcare priorities, addressing the need for effective treatments against infectious diseases. The consistent demand for these medications in the UAE market likely drives the company's import strategy. By concentrating on these therapeutic areas, IDA Trading MEA can leverage specialized knowledge and establish strong relationships with healthcare providers and patients requiring these treatments.

2Sourcing Profile

IDA Trading MEA's sourcing strategy is centered on importing generic drug formulations from India, specifically miconazole and tetracycline. This approach allows the company to offer cost-effective alternatives to branded medications, catering to the price-sensitive segments of the UAE market. India's established pharmaceutical manufacturing capabilities and adherence to international GMP standards make it a reliable source for these products.

3Market Positioning

Based on their product mix, IDA Trading MEA serves the wholesale distribution segment of the UAE pharmaceutical market. By importing essential medications like antifungals and antibiotics, the company supplies these products to various healthcare facilities, including hospitals, clinics, and pharmacies. Their focus on generic formulations positions them to meet the demand for affordable healthcare solutions within the UAE.

Seller's Guide — How to Become a Supplier to IDA Trading MEA

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with IDA Trading MEA, especially those manufacturing miconazole and tetracycline. The company's concentrated sourcing strategy indicates a preference for specific products, and establishing a relationship with IDA Trading MEA could facilitate entry into the UAE market. However, the limited product range may also present challenges in terms of growth and diversification opportunities.

2Requirements & Qualifications

Indian exporters seeking to supply IDA Trading MEA and the UAE market must ensure that their products comply with the UAE's regulatory standards. This includes obtaining GMP certifications recognized by the UAE, such as EU GMP, WHO GMP, or PIC/S. Additionally, products must meet the quality, safety, and efficacy standards set by the MOHAP and EDE. Proper labeling in Arabic and English, along with adherence to serialization mandates, is also required.

3How to Approach

Frequently Asked Questions — IDA Trading MEA

What products does IDA Trading MEA import from India?

IDA Trading MEA imports 2 pharmaceutical products across 2 categories. Top imports: Miconazole ($191.9K), Tetracycline ($140.8K).

Who supplies pharmaceuticals to IDA Trading MEA from India?

IDA Trading MEA sources from 33 verified Indian suppliers. The primary supplier is Medopharm (37.2% of imports, $6.2M).

What is IDA Trading MEA's total pharmaceutical import value?

IDA Trading MEA's total pharmaceutical import value from India is $332.7K, based on 32 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does IDA Trading MEA focus on?

IDA Trading MEA imports across 2 categories. The largest: Antifungals (57.7%), Antibiotics (42.3%).

Get Full IDA Trading MEA Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.